CMS has policies that effect the use of Erythropoietin Stimulating Agents in ESRD facilities. To find out more, click on the links below.
ESA Monitoring Policy, Effective October 1, 2006 [PDF, 151 KB]
ESA Monitoring Policy, Effective April 1, 2006 [PDF, 173 KB]
Page Last Modified: 01/06/2009 11:22:47 AM Help with File Formats and Plug-Ins